Syncona Portfolio
Latest statistics and disclosures from Syncona Portfolio's latest quarterly 13F-HR filing:
- Top 5 stock holdings are AUTL, ACHL, FRLN, ADAP, and represent 100.00% of Syncona Portfolio's stock portfolio.
- Syncona Portfolio has $62B in assets under management (AUM), dropping by -2.36%.
- Central Index Key (CIK): 0001725042
Tip: Access up to 7 years of quarterly data
Positions held by Syncona Portfolio consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Syncona Portfolio
Syncona Portfolio holds 4 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Autolus Therapeutics Spon Ads (AUTL) | 63.9 | $39B | 21M | 1840.00 |
|
|
| Achilles Therapeutics Sponsored Ads (ACHL) | 17.3 | $11B | 11M | 957.50 |
|
|
| Freeline Therapeutics Hldgs Sponsored Ads (FRLN) | 16.4 | $10B | 22M | 460.00 |
|
|
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 2.4 | $1.5B | 1.4M | 1090.00 |
|
Past Filings by Syncona Portfolio
SEC 13F filings are viewable for Syncona Portfolio going back to 2021
- Syncona Portfolio 2023 Q1 filed May 12, 2023
- Syncona Portfolio 2022 Q4 filed Feb. 14, 2023
- Syncona Portfolio 2022 Q3 filed Nov. 4, 2022
- Syncona Portfolio 2022 Q2 filed Aug. 10, 2022
- Syncona Portfolio 2022 Q1 filed May 31, 2022
- Syncona Portfolio 2021 Q4 filed Feb. 11, 2022